KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Free Cash Flow: 2009-2024

Historic Free Cash Flow for Sarepta Therapeutics (SRPT) over the last 16 years, with Dec 2024 value amounting to -$342.7 million.

  • Sarepta Therapeutics' Free Cash Flow rose 65.25% to -$37.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$381.1 million, marking a year-over-year increase of 18.98%. This contributed to the annual value of -$342.7 million for FY2024, which is 40.61% up from last year.
  • Latest data reveals that Sarepta Therapeutics reported Free Cash Flow of -$342.7 million as of FY2024, which was up 40.61% from -$577.1 million recorded in FY2023.
  • In the past 5 years, Sarepta Therapeutics' Free Cash Flow registered a high of $25.3 million during FY2020, and its lowest value of -$577.1 million during FY2023.
  • Its 3-year average for Free Cash Flow is -$425.3 million, with a median of -$356.2 million in 2022.
  • Per our database at Business Quant, Sarepta Therapeutics' Free Cash Flow surged by 104.90% in 2020 and then slumped by 2,006.52% in 2021.
  • Over the past 5 years, Sarepta Therapeutics' Free Cash Flow (Yearly) stood at $25.3 million in 2020, then plummeted by 2,006.52% to -$481.7 million in 2021, then grew by 26.05% to -$356.2 million in 2022, then crashed by 62.03% to -$577.1 million in 2023, then surged by 40.61% to -$342.7 million in 2024.